Stories
US Waives Tariffs on Speciality Drugs from India, 19 Other Nations
N
News18•28-09-2026, 21:30
US Waives Tariffs on Speciality Drugs from India, 19 Other Nations
- •The US will not impose ad valorem tariffs on certain speciality drugs and associated ingredients imported from India and 19 other countries, used for rare medical conditions.
- •This exemption is part of President Donald Trump's April proclamation to impose tariffs on patented pharmaceutical imports to encourage domestic production.
- •Eligible products for the zero percent tariff rate include drugs for rare diseases, infertility treatments, cell therapies, gene therapies, antibody-drug conjugates (ADCs), and animal pharmaceuticals, along with their components.
- •The 20 countries, including India, qualify for zero percent tariffs due to existing or forthcoming trade and security framework agreements with the US.
- •Generic pharmaceutical products and their associated ingredients are not subject to these Section 232 pharmaceutical tariffs.
Key Questions Answered
India is among 20 countries, including Japan, Switzerland, Britain, and the European Union, exempt from ad valorem tariffs on specialty drugs and associated ingredients for rare medical conditions.
Eligible products subject to a zero per cent tariff rate include all drugs designated for rare diseases, infertility treatments, cell therapies, gene therapies, antibody-drug conjugates, and animal pharmaceuticals, along with their components.
Qualifying products receive a zero per cent tariff because these jurisdictions have a current or forthcoming trade and security framework agreement with the US, under Section 232 of the Trade Expansion Act.
